In this study, we explored the mechanism underlying TXNIP’s tumor suppression activities using two ER/PR negative BC models - MDA-MB-231 (TNBC; high TXNIP expression) and HCC-1954 (HER2-positive; low TXNIP expression) [22]. This evidence concerns the gene TXNIP and hepatocellular carcinoma.